Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer

Mr. Pfreundschuh will be based in Y-mAbs' New York and New Jersey offices. Forward-Looking Statements DANYELZA® and Y-mAbs® are registered trademarks of Y-mAbs Therapeutics, Inc. "I am thrilled to join the Y-mAbs team during this pivotal time for the company," said Mr. Pfreundschuh. "With a solid financial foundation fueled by the growing commercial success of DANYELZA® on a global scale, I believe Y-mAbs is well positioned to further advance our SADA-PRIT technology platform and materially change the way w ...